Trial Profile
A Single Center, Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus Modified Release, ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- 08 Feb 2018 New trial record